Yeast Infections in Black Women: Symptoms, Treatment, Recurrence

The medical name is vulvovaginal candidiasis. Candida, usually Candida albicans, is a fungus that lives in the vagina alongside protective bacteria. When the balance tips, Candida overgrows and causes symptoms. It is not a sexually transmitted infection, and it is not a sign of poor hygiene. The CDC estimates that about 75% of women will have at least one episode of vulvovaginal candidiasis, and 40% to 45% will have two or more.

The classic signs are an intense itch, redness and swelling of the vulva, burning, and a thick white discharge often compared to cottage cheese. There is usually no strong odor. Sex and urination can sting. Those symptoms feel specific, but they overlap heavily with two other conditions, and that overlap is where most of the trouble starts.

Three different conditions cause itch, discharge, and irritation, and they are treated three different ways. Getting the wrong one wastes time and money and can leave a real infection untreated.

• Yeast infection. Thick, white, clumpy discharge. Intense itch. Usually no odor. Treated with antifungals.
• Bacterial vaginosis (BV). Thin, gray or white discharge. A fishy odor that is stronger after sex. Often little or no itch. Treated with antibiotics, not antifungals. BV is the most common vaginal condition and is two to three times more common in Black women. Our guide to bacterial vaginosis in Black women covers why.
• Trichomoniasis (trich). Frothy, yellow-green discharge, odor, itch, and sometimes pain with urination. It is a sexually transmitted infection caused by a parasite and is treated with oral antibiotics. A partner needs treatment too.

You cannot reliably sort these out by symptoms alone, and neither can most women who have had a yeast infection before. In a study led by Daron Ferris, researchers examined 95 symptomatic women who had already self-diagnosed a yeast infection and bought an over-the-counter antifungal. Only 33.7% actually had a yeast infection. The rest had bacterial vaginosis (18.9%), a mix of conditions (21.1%), normal findings (13.7%), trichomoniasis (2.1%), or something else. Having been diagnosed before did not improve accuracy, and neither did reading the package label.

The practical takeaway: if it is your first time, if the symptoms are not classic, or if an OTC cream did not work within a few days, see a clinician for a test. A quick microscope check or pH test settles it. The CDC notes that even women previously diagnosed with a yeast infection are not necessarily better at diagnosing themselves.

The disparity picture for yeast infections is less settled than it is for BV. The strongest historical signal comes from a 2000 national survey by Betsy Foxman and colleagues, who used random-digit dialing to reach 2,000 US women. Black women reported about three times more yeast infections in the prior two months (17.4%) than white women (5.8%). That is self-reported and presumed, not lab-confirmed, but it tracks with the broader pattern of vaginal-health disparities.

More recent data complicates that. A 2022 nationally representative survey by Kaitlin Benedict and CDC colleagues found that 53% of women had ever been diagnosed with a yeast infection, but after controlling for other factors, race and ethnicity showed no significant association with it. In plain terms: the older self-report data showed Black women reporting more, and the newer adjusted analysis did not find a racial gap once other variables were accounted for. The honest summary is that the disparity in confirmed yeast infections is uncertain, unlike BV, where the gap is large and consistent.

Where the Black-patient angle is concrete is downstream. Because BV is far more common in Black women and looks like yeast, a Black woman with vaginal symptoms is statistically more likely to actually have BV than yeast. Reaching for a drugstore antifungal on a guess is more likely to be the wrong move. That is a reason to get a test rather than self-treat, especially when symptoms keep coming back.

Most yeast infections are uncomplicated, meaning they are occasional, mild to moderate, caused by Candida albicans, and in someone without a weakened immune system. These respond well to short courses of antifungals. The CDC-listed options include:

• Over-the-counter creams and suppositories: clotrimazole, miconazole, or tioconazole, in 1-day, 3-day, or 7-day courses.
• A single prescription pill: fluconazole 150 mg by mouth, one dose.
• Prescription topicals: butoconazole or terconazole creams.

Oral fluconazole and the topical products work about equally well for uncomplicated cases. The pill is more convenient; the creams avoid a systemic drug and can soothe external itch faster. Either is reasonable.

Complicated cases are different. That category includes severe symptoms, recurrent infections, non-albicans species like Candida glabrata, pregnancy, uncontrolled diabetes, or a weakened immune system. These need longer treatment and often a culture to identify the species, because some non-albicans yeasts do not respond to fluconazole. Pregnant women should use topical azoles, not oral fluconazole.

Recurring yeast infections can be a flag for blood sugar. Candida feeds on glucose. When blood sugar runs high, glucose rises in vaginal secretions and spills into the urine, which gives the fungus more fuel and makes infections more frequent and harder to clear. A 2022 review by Jasminka Talapko and colleagues in the World Journal of Diabetes describes how uncontrolled hyperglycemia drives urogenital candidiasis and impairs the immune cells that normally keep Candida in check.

There is a medication angle too. SGLT2 inhibitors, a common class of type 2 diabetes drugs that work by flushing glucose out through the urine, raise the rate of genital yeast infections. The same review notes Candida colonization can climb to around 37% with these agents. Black adults carry a higher burden of type 2 diabetes, so for many Black women, repeated yeast infections and blood sugar are worth looking at together. Our guide to type 2 diabetes in Black adults covers screening and control. If you get four or more yeast infections a year and have not been screened for diabetes, raise it with your clinician.

Recurrent vulvovaginal candidiasis means three or more symptomatic, confirmed episodes in a year. It affects fewer than 5% of women, but it is miserable and it is treatable with a structured plan rather than a string of one-off creams. The CDC approach has two phases. First, an induction course to clear the infection: 7 to 14 days of a topical antifungal, or oral fluconazole on days 1, 4, and 7. Then maintenance: oral fluconazole once a week for six months.

Maintenance therapy controls recurrence well but is rarely a permanent cure; symptoms can return after it stops. Two things make the plan work. One, the diagnosis has to be confirmed by culture, not assumed, because non-albicans species and azole-resistant Candida are more common in women who keep relapsing and they need different drugs. Two, fixable drivers like uncontrolled blood sugar get addressed at the same time. Self-treating recurrent infections with drugstore products on repeat is the pattern that delays real care.

Yeast infections are diagnosed and treated by a primary care clinician, an OB-GYN, a nurse practitioner, or a sexual-health clinic. If you want a clinician who will run the test instead of waving you toward the drugstore, you can find a Black OB-GYN or primary care clinician in our directory. Bring a short note of what the discharge looks like, whether there is an odor, when symptoms started, and how many times this has happened in the past year. That detail decides whether you get a single dose or a six-month plan, and whether a culture is worth running.